Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Tsuda

Showing results (301-310 of 477) with videos related to

Pageof 48
Sort By:
Cancer Medicine|May 8, 2018
A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cellsTakayuki Ueno, Norikazu Masuda, Shunji Kamigaki, et al.
Archives of Gynecology and Obstetrics|May 4, 2022
The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomasHiroko Matsuura, Morikazu Miyamoto, Taira Hada, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 10, 2003
Interlaboratory comparison in HercepTest assessment of HER2 protein status in invasive breast carcinoma fixed with various formalin-based fixativesKaoru Hashizume, Yutaka Hatanaka, Yuki Kamihara, et al.
Japanese Journal of Clinical Oncology|July 2, 2011
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancerHiroji Iwata, Nobuaki Sato, Norikazu Masuda, et al.
The American Journal of Surgical Pathology|July 15, 2011
Comprehensive histologic analysis of ALK-rearranged lung carcinomasAkihiko Yoshida, Koji Tsuta, Harumi Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcomeEri Arai, Saori Ushijima, Hitoshi Tsuda, et al.
Journal of Proteomics|June 28, 2012
Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancerYutaka Sugihara, Hirokazu Taniguchi, Ryoji Kushima, et al.
Oncogene|August 17, 2005
ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylationHisashi Takada, Issei Imoto, Hitoshi Tsuda, et al.
Oncology Letters|March 17, 2018
JAK2/STAT3 pathway as a therapeutic target in ovarian cancersTomoyuki Yoshikawa, Morikazu Miyamoto, Tadashi Aoyama, et al.
World Journal of Urology|May 24, 2024
High frequency of concomitant squamous metaplasia in bulbar urethral stricture and its association with reconstructive delay and urethral restYusuke Hirano, Akio Horiguchi, Masayuki Shinchi, et al.
Pageof 48

Showing results (301-310 of 477) with videos related to

Sort By:
Pageof 48
Cancer Medicine|May 8, 2018
A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cellsTakayuki Ueno, Norikazu Masuda, Shunji Kamigaki, et al.
Archives of Gynecology and Obstetrics|May 4, 2022
The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomasHiroko Matsuura, Morikazu Miyamoto, Taira Hada, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 10, 2003
Interlaboratory comparison in HercepTest assessment of HER2 protein status in invasive breast carcinoma fixed with various formalin-based fixativesKaoru Hashizume, Yutaka Hatanaka, Yuki Kamihara, et al.
Japanese Journal of Clinical Oncology|July 2, 2011
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancerHiroji Iwata, Nobuaki Sato, Norikazu Masuda, et al.
The American Journal of Surgical Pathology|July 15, 2011
Comprehensive histologic analysis of ALK-rearranged lung carcinomasAkihiko Yoshida, Koji Tsuta, Harumi Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcomeEri Arai, Saori Ushijima, Hitoshi Tsuda, et al.
Journal of Proteomics|June 28, 2012
Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancerYutaka Sugihara, Hirokazu Taniguchi, Ryoji Kushima, et al.
Oncogene|August 17, 2005
ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylationHisashi Takada, Issei Imoto, Hitoshi Tsuda, et al.
Oncology Letters|March 17, 2018
JAK2/STAT3 pathway as a therapeutic target in ovarian cancersTomoyuki Yoshikawa, Morikazu Miyamoto, Tadashi Aoyama, et al.
World Journal of Urology|May 24, 2024
High frequency of concomitant squamous metaplasia in bulbar urethral stricture and its association with reconstructive delay and urethral restYusuke Hirano, Akio Horiguchi, Masayuki Shinchi, et al.
Pageof 48